Fact CheckerSign in

NCT05563142Completed

Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation

Venous Vascular Closure System Versus Manual Compression Following Single Shot Device AF Ablation - the Style-AF Study

Source: ClinicalTrials.gov · Last updated 1 Jul 2024

Brief summary (registry, in English)

Prospective, randomized, controlled, multi-center study to compare the safety and efficacy of the Perclose ProStyle suture-mediated closure device (PPS) as to manual compression (MC) for venous hemostasis following single shot device (SSD) based pulmonary vein isolation (PVI).

Status (registry)
Completed
Study type
Interventional
Enrollment
125 (actual)
First submitted
27 Sept 2022
Start date
22 Nov 2022
Primary completion date
1 Mar 2024
Lead sponsor
University of Luebeck
NCT number
NCT05563142

What you commit to

  • Study type: Interventional
  • Participants enrolled: 125
  • From 22 Nov 2022 to the primary completion date, 1 Mar 2024
  • 3 sites in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Active systemic or cutaneous infection, or inflammation in vicinity of the groin
  • Intraprocedural bleeding or thrombotic complications

Lab values

  • Platelet count \< 100,000 cells/mm3

Other

  • BMI \> 45 kg/m2 or \< 20 kg/m2
  • Attempted femoral arterial access or inadvertent arterial puncture
  • Procedural complications that interfered with routine recovery, ambulation, or discharge times
  • Incorrect sheath placement
  • Access site-specific eligibility criteria to exclude problems with gaining access or location of sheath

Who the study is looking for

  • Patients age \>18
  • Elective catheter ablation for atrial fibrillation using a 6 to 14 Fr inner diameter introducer sheath with a minimum of 1 and maximum of 2 femoral venous access sites

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (3)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Herz- und Diabeteszentrum Nordrhein-Westfalen
Coordinator of this site? Confirm its status
Bad OeynhausenGermanyUnknown status
Klinik für Innere Medizin III
Coordinator of this site? Confirm its status
KielGermanyUnknown status
Klinik für Rhythmologie
Coordinator of this site? Confirm its status
LübeckGermanyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.